Showing results (51-60 of 145) with videos related to

Sort By:
Pageof 15
Journal of Medical Economics|April 7, 2023
Assessing the impact of single or short-term administration on a therapy's cost-effectiveness: a hypothetical disease-agnostic modelAlexa C Klimchak, Lauren E Sedita, Katherine L Gooch, et al.
BMC Cancer|August 19, 2010
Systematic Review of topotecan (Hycamtin) in relapsed small cell lung cancerRob Riemsma, Jean P Simons, Zahid Bashir, et al.
Journal of Patient-Reported Outcomes|November 20, 2021
Characterizing the quality-of-life impact of Duchenne muscular dystrophy on caregivers: a case-control investigationCarolyn E Schwartz, Roland B Stark, Ivana F Audhya, et al.
Journal of Cell Science|June 1, 2006
Loss of calcineurin Aalpha results in altered trafficking of AQP2 and in nephrogenic diabetes insipidusJennifer L Gooch, Rebecca L Guler, Jeffrey L Barnes, et al.
Journal of Clinical Neuromuscular Disease|June 5, 2009
Subjective improvement in proprioception in 2 patients with atypical Friedreich ataxia treated with varenicline (Chantix)Theresa A Zesiewicz, Kelly L Sullivan, Clifton L Gooch, et al.
Research in Veterinary Science|January 1, 1996
Retinal pigment epithelial dystrophy in Briard dogsR M Lightfoot, L Cabral, L Gooch, et al.
Plos One|April 18, 2017
Cyclosporine A alters expression of renal microRNAs: New insights into calcineurin inhibitor nephrotoxicityJennifer L Gooch, Clayton King, Cynthia E Francis, et al.
Health and Quality of Life Outcomes|June 11, 2022
Factors associated with the health-related quality of life among people with Duchenne muscular dystrophy: a study using the Health Utilities Index (HUI)Shelagh M Szabo, Ivana F Audhya, Basia Rogula, et al.
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|August 28, 2010
Muscle atrophy in chronic kidney disease results from abnormalities in insulin signalingS Russ Price, Jennifer L Gooch, Sue K Donaldson, et al.
Molecular and Cellular Biology|February 12, 2000
Insulin-like growth factor I-induced degradation of insulin receptor substrate 1 is mediated by the 26S proteasome and blocked by phosphatidylinositol 3'-kinase inhibitionA V Lee, J L Gooch, S Oesterreich, et al.
Pageof 15